Cargando…
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
Cancer therapy can be associated with short- and long-term cardiac dysfunction. Patients with cancer often exhibit therapy-related clonal hematopoiesis (t-CH), an aggressive form of clonal hematopoiesis that can result from somatic mutations in genes encoding regulators of the DNA-damage response (D...
Autores principales: | Yura, Yoshimitsu, Miura-Yura, Emiri, Katanasaka, Yasufumi, Min, Kyung-Duk, Chavkin, Nicholas, Polizio, Ariel H., Ogawa, Hayato, Horitani, Keita, Doviak, Heather, Evans, Megan A., Sano, Miho, Wang, Ying, Boroviak, Katharina, Philippos, George, Domingues, Ana Filipa, Vassiliou, George, Sano, Soichi, Walsh, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409899/ https://www.ncbi.nlm.nih.gov/pubmed/34315245 http://dx.doi.org/10.1161/CIRCRESAHA.121.319314 |
Ejemplares similares
-
TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response
por: Sano, Soichi, et al.
Publicado: (2021) -
JAK2(V617F)-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
por: Sano, Soichi, et al.
Publicado: (2019) -
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
por: Yura, Yoshimitsu, et al.
Publicado: (2020) -
Employing the CRISPR-Cas System for Clonal Hematopoiesis Research
por: Ogawa, Hayato, et al.
Publicado: (2021) -
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
por: Hsu, Joanne I., et al.
Publicado: (2018)